Integral Molecular

Integral Molecular company information, Employees & Contact Information

Integral Molecular is a research-driven biotechnology company specializing in antibodies, viruses, and membrane proteins. We develop technologies for solving big scientific challenges and advancing therapies against difficult-to-treat diseases. Our products, platforms, and services enable antibody discovery, biotherapeutic safety profiling, vaccine development, protein engineering, and more. Learn why top pharmaceutical and biotechnology companies trust Integral Molecular. Instagram: IntegralMolecular

Company Details

Employees
117
Founded
-
Address
One Ucity Square 25 N. 38th Street St,
Phone
215-966-6061
Email
in****@****lar.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Philadelphia, Pennsylvania
Looking for a particular Integral Molecular employee's phone or email?

Integral Molecular Questions

News

Integral Molecular's Membrane Proteome Array™ Nears FDA Qualification as a Drug Development Tool - Yahoo Finance

Integral Molecular's Membrane Proteome Array™ Nears FDA Qualification as a Drug Development Tool Yahoo Finance

10x Faster Virus Neutralization Testing With Launch of Integral Molecular's Ready Reporter Virustm Kit - Lelezard

10x Faster Virus Neutralization Testing With Launch of Integral Molecular's Ready Reporter Virustm Kit Lelezard

Integral Molecular Named a Top Workplace by Philadelphia Inquirer - PR Newswire

Integral Molecular Named a Top Workplace by Philadelphia Inquirer PR Newswire

The emergence of cell-based protein arrays to test for polyspecific off-target binding of antibody therapeutics - Taylor & Francis Online

The emergence of cell-based protein arrays to test for polyspecific off-target binding of antibody therapeutics Taylor & Francis Online

Isolation of state-dependent monoclonal antibodies against the 12-transmembrane domain glucose transporter 4 using virus-like particles - PNAS

Isolation of state-dependent monoclonal antibodies against the 12-transmembrane domain glucose transporter 4 using virus-like particles PNAS

Identification of the seven critical residues that control ZIKV-DENV cross-reactivity to engineer a non-cross-reactive ZIKV vaccine - ScienceDirect.com

Identification of the seven critical residues that control ZIKV-DENV cross-reactivity to engineer a non-cross-reactive ZIKV vaccine ScienceDirect.com

Full article: The emergence of cell-based protein arrays to test for polyspecific off-target binding of antibody therapeutics - Taylor & Francis Online

Full article: The emergence of cell-based protein arrays to test for polyspecific off-target binding of antibody therapeutics Taylor & Francis Online

Screening the Membrane Proteome - Genetic Engineering and Biotechnology News

Screening the Membrane Proteome Genetic Engineering and Biotechnology News

Lab Notes: Integral Molecular opens new HQ at uCity Square with plans to double its workforce - The Business Journals

Lab Notes: Integral Molecular opens new HQ at uCity Square with plans to double its workforce The Business Journals

Integral Molecular Awarded $2.7 Million to Advance the Membrane Proteome Array™ Towards FDA-Qualification as a Drug Development Tool - PR Newswire

Integral Molecular Awarded $2.7 Million to Advance the Membrane Proteome Array™ Towards FDA-Qualification as a Drug Development Tool PR Newswire

Signal transmission through the CXC chemokine receptor 4 (CXCR4) transmembrane helices - PNAS

Signal transmission through the CXC chemokine receptor 4 (CXCR4) transmembrane helices PNAS

Membrane Protein Solutions for Antibody Discovery - Genetic Engineering and Biotechnology News

Membrane Protein Solutions for Antibody Discovery Genetic Engineering and Biotechnology News

Integral Molecular Breaks Ground on New Headquarters, Doubling in Size - PR Newswire

Integral Molecular Breaks Ground on New Headquarters, Doubling in Size PR Newswire

Integral Molecular Out-Licenses First-in-Class Antibody Panel Targeting SLC2A4 Glucose Transporter - PR Newswire

Integral Molecular Out-Licenses First-in-Class Antibody Panel Targeting SLC2A4 Glucose Transporter PR Newswire

Integral Molecular's Out-licensed Bispecific Antibody Enters Clinical Trial for Treating Solid Tumors - PR Newswire

Integral Molecular's Out-licensed Bispecific Antibody Enters Clinical Trial for Treating Solid Tumors PR Newswire

FDA Accepts Integral Molecular's Membrane Proteome Array™ Qualification Plan, Advancing the Platform for Approval as a Drug Development Tool - PR Newswire

FDA Accepts Integral Molecular's Membrane Proteome Array™ Qualification Plan, Advancing the Platform for Approval as a Drug Development Tool PR Newswire

Integral Molecular Licenses Claudin 18.2 Monoclonal Antibodies to CARTEXELL for Oncology Cell Therapies - PR Newswire

Integral Molecular Licenses Claudin 18.2 Monoclonal Antibodies to CARTEXELL for Oncology Cell Therapies PR Newswire

Tunneling Splittings in Water Clusters from Path Integral Molecular Dynamics - ACS Publications

Tunneling Splittings in Water Clusters from Path Integral Molecular Dynamics ACS Publications

Maximal Humanization of Monoclonal Abs - Genetic Engineering and Biotechnology News

Maximal Humanization of Monoclonal Abs Genetic Engineering and Biotechnology News

High-Throughput Alanine Scanning - Genetic Engineering and Biotechnology News

High-Throughput Alanine Scanning Genetic Engineering and Biotechnology News

Top Integral Molecular Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant